- Trials with a EudraCT protocol (95)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
95 result(s) found for: Complex cells.
Displaying page 1 of 5.
EudraCT Number: 2005-004590-24 | Sponsor Protocol Number: 1949 | Start Date*: 2005-10-10 | |||||||||||
Sponsor Name:AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO | |||||||||||||
Full Title: PHASE II PILOT PROTOCOL OF BONEMARROW STAM CELLS MOBILIZATION BY CYTOCHINE STIMULATION IN PATIENTS WITH COMPLEX ANAL FISTULAS AND/OR RECURRENCES AND/OR ANAL-PERIANAL LOCALIZATIONS OF IBD | |||||||||||||
Medical condition: PATIENTS WITH COMPLEX ANAL FISTULAS AND/OR RECURRENCES AND/OR ANAL-PERIANAL LOCALIZATIONS OF IBD | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002805-13 | Sponsor Protocol Number: LTF-304 | Start Date*: 2015-11-27 | |||||||||||
Sponsor Name:bluebird bio, Inc | |||||||||||||
Full Title: Longterm Follow-up of Subjects With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product | |||||||||||||
Medical condition: Cerebral Adrenoleukodystrophy (CALD) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) FR (Trial now transitioned) DE (Trial now transitioned) NL (Trial now transitioned) IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001953-10 | Sponsor Protocol Number: ALD-102 | Start Date*: 2013-12-13 | |||||||||||
Sponsor Name:bluebird bio, Inc. | |||||||||||||
Full Title: A phase 2/3 study of the efficacy and safety of hematopoietic stem cells transduced with Lenti D lentiviral vector for the treatment of cerebral adrenoleukodystrophy (CALD) | |||||||||||||
Medical condition: Cerebral Adrenoleukodystrophy (CALD) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) FR (Completed) DE (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-003193-48 | Sponsor Protocol Number: Darvadstrocel-3004 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Takeda Development Center Americas, Inc. | |||||||||||||
Full Title: A Phase 3, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of Darvadstrocel in the Treatment of Complex Perianal Fistula in Pediatric Subjects with Crohn’s Disease over a Period o... | |||||||||||||
Medical condition: Complex Perianal Fistulas in Crohn’s Disease | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Trial now transitioned) NL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-000040-13 | Sponsor Protocol Number: 21011075118 | Start Date*: 2009-02-11 |
Sponsor Name:Medizinische Universität Innsbruck, Univ.-Klinik für Neurologie | ||
Full Title: Effects of recombinant human Erythropoietin on circulating and intramuscular endothelial progenitor cells, neovascularisation and oxidative metabolism of skeletal muscle in Friedreich’s Ataxia | ||
Medical condition: Friedreich's ataxia (FRDA) is the most common autosomal recessive neurodegenerativ disease (1:50 000) affecting the central and peripheral nervous system. Extraneural organs are also affected durin... | ||
Disease: | ||
Population Age: | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-001087-38 | Sponsor Protocol Number: PI2017_843_0010 | Start Date*: 2017-09-15 |
Sponsor Name:CHU Amiens-Picardie | ||
Full Title: CLArithromycin versus AZIthromycin in the treatment of Mycobacterium avium complex pulmonary infections: A randomized prospective controlled study | ||
Medical condition: Mycobacterium avium complex pulmonary infections | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001145-14 | Sponsor Protocol Number: ALD-104 | Start Date*: 2019-04-17 | |||||||||||
Sponsor Name:bluebird bio, Inc. | |||||||||||||
Full Title: A Phase 3 Study of Lenti-D Drug Product After Myeloablative Conditioning Using Busulfan and Fludarabine in Subjects ≤17 Years of Age With Cerebral Adrenoleukodystrophy (CALD) | |||||||||||||
Medical condition: Cerebral Adrenoleukodystrophy (CALD) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) FR (Ongoing) DE (Completed) NL (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-004286-25 | Sponsor Protocol Number: CX-401/FATT2 | Start Date*: 2008-12-04 | |||||||||||
Sponsor Name:CELLERIX S.A. | |||||||||||||
Full Title: Estudio fase III, multicéntrico, simple ciego, randomizado, controlado con placebo, para evaluar la eficacia y seguridad de células madre expandidas derivadas de tejido adiposo autólogo (eASCs) (CX... | |||||||||||||
Medical condition: Fístula perianal compleja en pacientes con enfermedad de Crohn. Complex perianal fistula in perianal Crohn´s disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) NL (Completed) AT (Prematurely Ended) DE (Prematurely Ended) BE (Completed) CZ (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-001755-38 | Sponsor Protocol Number: J32B11JM54 | Start Date*: 2005-11-04 |
Sponsor Name:Fundación Teknon | ||
Full Title: Clinical Trial phase I-II, Multicentic of the Application of TRC in the Surgical Treatment of Non-Hypertrophic Pseudoarthrosis and Complex Fractures of Long Bones Ensayo Clínico Fase I-II, multicén... | ||
Medical condition: Surgical Treatment of Non-Hypertrophic Pseudoarthrosis and Complex Fractures of Long Bones | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-003370-95 | Sponsor Protocol Number: Cx401/FATT1 | Start Date*: 2008-02-06 | |||||||||||
Sponsor Name:CELLERIX, S.L. | |||||||||||||
Full Title: "A Phase III multicenter, single blind, randomized, comparative, add?on clinical trial, in three parallel groups, to evaluate the efficacy and safety of a new therapy with adipose?derived autologou... | |||||||||||||
Medical condition: Treatment of complex perianal fistulas in patients without inflammatory bowel disease. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) NL (Prematurely Ended) ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002649-41 | Sponsor Protocol Number: LEX-209 | Start Date*: 2017-06-19 | |||||||||||
Sponsor Name:Octapharma Pharmazeutika Produktionsges.m.b.H | |||||||||||||
Full Title: A Phase III, randomized, double-blind, multicenter study to assess the efficacy and safety of OCTAPLEX, a four-factor prothrombin complex concentrate (4F-PCC), compared to the 4F-PCC Beriplex® P/N ... | |||||||||||||
Medical condition: Reversal of vitamin K antagonist (VKA) induced anticoagulation in patients needing urgent surgery associated with significant bleeding risk. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) PL (Completed) ES (Prematurely Ended) BG (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-000333-39 | Sponsor Protocol Number: Darvadstrocel-3003 | Start Date*: 2019-10-15 | |||||||||||
Sponsor Name:Takeda Development Center Americas, Inc | |||||||||||||
Full Title: A Follow-up of a Phase 3 Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel in the Treatment of Complex Perianal Fistula in Subjects With Crohn’s Disease Who Have Participated in ... | |||||||||||||
Medical condition: Perianal fistulising Crohn´s disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) FR (Completed) HU (Completed) ES (Completed) BE (Completed) PL (Completed) IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001178-28 | Sponsor Protocol Number: FISPAC-2011 | Start Date*: 2012-09-05 |
Sponsor Name:Fundación para la Investigación Biomédica del Hospital Universitario La Paz | ||
Full Title: Multicentre, randomized, comparative and Add-on, in two parallel groups to assess the efficacy and safety of autologous mesenchymal stem cells derived from expanded adipose tissue (ASC) for the tre... | ||
Medical condition: Local treatment in complex perianal fistulas in patients without inflammatory bowel disease | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-003959-11 | Sponsor Protocol Number: 1703001 | Start Date*: 2020-05-25 |
Sponsor Name:Vestre Viken Trust | ||
Full Title: MUscle Side-Effects of atorvastatin in coronary patients (MUSE) follow-up study | ||
Medical condition: Coronary heart disease patients With perceived statin Associated muscle symptoms or statin discontinuaton due to muscle symptoms | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-014775-42 | Sponsor Protocol Number: CX-401-0304 | Start Date*: 2009-12-28 | |||||||||||
Sponsor Name:CELLERIX S.A. | |||||||||||||
Full Title: Estudio prospectivo para la evaluación de la seguridad y eficacia a largo plazo de Cx401 en pacientes que hayan participado en el ensayo clínico FATT2. A prospective study for the assessment of th... | |||||||||||||
Medical condition: Fistula perianal compleja en la enfermedad perianal de Crohn Complex perianal fistula in perianal Crohn´s disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002491-10 | Sponsor Protocol Number: Alofisel-4001 | Start Date*: 2020-03-10 | |||||||||||
Sponsor Name:Takeda Development Center Americas, Inc. | |||||||||||||
Full Title: Postauthorization Safety Study of the Long-Term Safety and Efficacy of Repeat Administration of Darvadstrocel in Patients With Crohn’s Disease and Complex Perianal Fistula | |||||||||||||
Medical condition: Perianal fistulising Crohn´s disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Trial now transitioned) ES (Trial now transitioned) DE (Trial now transitioned) FR (Trial now transitioned) AT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-004313-15 | Sponsor Protocol Number: NI-0401-01 | Start Date*: 2006-07-14 |
Sponsor Name:NovImmune S.A. | ||
Full Title: A Phase I/IIa, Double-blind, Randomized, Placebo-controlled, Dose-Escalation Study of NI-0401 in Patients with Moderate to Severe Active Crohn´s Disease | ||
Medical condition: Moderate to Severe Active Crohn´s Disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-006016-33 | Sponsor Protocol Number: E410/2007 | Start Date*: 2008-09-30 |
Sponsor Name:Uniklinikum Tuebingen | ||
Full Title: Multicenter Phase II study of haploidentical hematopoietic cell transplantation with CD3/CD19 depleted grafts after a reduced intensity conditioning regimen for adult patients with acute leukemia | ||
Medical condition: Patients with acute leukemia with an indication for allogeneic HCT but without a suitable HLA-identical donor | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2017-000725-12 | Sponsor Protocol Number: Cx601-0303 | Start Date*: 2017-08-08 | |||||||||||
Sponsor Name:TiGenix, S.A.U. | |||||||||||||
Full Title: A phase III, randomized, double blind, parallel group, placebo controlled, international, multicentre study to assess efficacy and safety of Cx601, adult allogeneic expanded adipose-derived stem ce... | |||||||||||||
Medical condition: Perianal fistulising Crohn´s disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) BE (Completed) ES (Completed) HU (Completed) PL (Completed) GB (GB - no longer in EU/EEA) DE (Completed) FR (Completed) SE (Completed) DK (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-021221-12 | Sponsor Protocol Number: UMC Utrecht | Start Date*: 2011-07-11 | |||||||||||
Sponsor Name:UMCU | |||||||||||||
Full Title: A phase I/ II study Efficacy and safety of alpha/beta T- /CD19B-cell depleted allogeneic haematopoietic stem cells transplantation in high risk or relapsed acute leukaemia / MDS followed by an inn... | |||||||||||||
Medical condition: Patients with high risk acute leukemia / MDS or relapse acute leukemia /MDS | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
